Advisors Asset Management’s CorMedix CRMD Stock Holding History

Advisors Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$196K	Sell	25,003 -235	-0.9%	-$1.86K	﹤0.01%	1172
2026 Q1	$171K	Sell	25,238 -742	-3%	-$5.49K	﹤0.01%	1177
2025 Q4	$302K	Buy	25,980 +11,869	+84%	+$131K	0.01%	1066
2025 Q3	$164K	Buy	14,111 +4,433	+46%	+$53.6K	﹤0.01%	1149
2025 Q2	$119K	Buy	+9,678	New	+$107K	﹤0.01%	1184

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Advisors Asset Management's CRMD Position: Q2 2026 in Review

Advisors Asset Management reduced its CorMedix (CRMD) stake by 0.93% in Q2 2026, selling an estimated $1.86K and leaving 25,003 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Advisors Asset Management first reported a position in CRMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $302K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Advisors Asset Management held 25,003 shares of CorMedix worth $196K as of Q2 2026.
Advisors Asset Management sold 235 CorMedix shares in Q2 2026, an estimated $1.86K.
CorMedix made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1172 holding.
Advisors Asset Management first reported a position in CorMedix in Q2 2025 and has held it in 5 quarters since.
Advisors Asset Management's CorMedix position peaked at $302K in Q4 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.